ODYSSEA PHARMA SPRL

DIAFERT

Medical apparatus and instruments, namely, diagnostic kits comprising of an immunoassay for the assessment if oocyte potency in invitro fertilization; medical apparatus and instruments, namely, diagnostic kits comprising of an immunassay used to predict the outcome of assisted fertilization in a female patient;Medical apparatus and instruments, namely, diagnostic kits comprising of an immunoassay for the assessment if oocyte potency in in-vitro fertilization; Medical apparatus and instruments, namely, diagnostic kits comprising of an immunassay used to predict the outcome of assisted fertilization in a female patient;

LEVOSERT

Pharmaceutical preparations, namely, hormone therapy products in the field of gynecology; sanitary preparations for medical purposes; contraceptive preparations; pharmaceutical preparations for treating menopause symptoms; vitamin preparations;Surgical and medical apparatus, namely, intra-uterine contraceptive devices;

LILETTA

Contraceptives; Pharmaceutical preparations for the prevention of pregnancy;

LILETTA

The wording LILETTA has no meaning in a foreign language.;Surgical and medical apparatus and instruments, namely, intra-uterine contraceptive devices;

LILETTA + LILETTA PATIENT COMMITMENT PROGRAM

The mark consists of the stylized wording LILETTA + LILETTA PATIENT COMMITMENT PROGRAM and design. The first term LILETTA is listed to the left of the prolate spheroids design all of which are differently-sized, originate from a central point and are arranged in a partially-overlapping, fanned orientation. A plus symbol appears below the letter E in the first term LILETTA. To the right of the plus symbol is the second term LILETTA. Below all of the above is the wording PATIENT COMMITMENT and the term PROGRAM appears below the term PATIENT.;LILETTA PLUS LILTTA PATIENT COMMITMENT PROGRAM;Color is not claimed as a feature of the mark.;Providing health care services, namely, providing healthcare information to patients by telephone and the internet; medical evaluation services, namely, functional assessment program for patients receiving drug treatment services for the purpose of monitoring patient's compliance with drug procedures and providing medical advisory services related thereto; providing medical information; providing medical information in the fields of health and disease prevention and treatment and pharmaceutical products via the internet and call centers;PATIENT COMMITMENT PROGRAM;